Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Philip Prorok

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Prostate-Specific Antigen

Geographic Areas

United States

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
16
Kramer, Barnett
13
Gohagan, John
9
Pinsky, Paul
7
Reding, Douglas
7
Xu, Jian-Lun
6
Hayes, Richard
6
Riley, Thomas
6
Weissfeld, Joel
6
Ragard, Lawrence
6
Andriole, Gerald
6
Baker, Stuart
5
Berg, Christine
5
Buys, Saundra
5
Schoen, Robert
4
Levin, David

Sign-in to see all Coauthors

Publications

TOP 3
Doria-Rose V Paul; Marcus Pamela M; Szabo Eva; Tockman Melvyn S; Melamed Myron R; Prorok Philip C
Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study.
Tammemagi Martin Carl; Freedman Matthew T; Pinsky Paul F; Oken Martin M; Hu Ping; Riley Thomas L; Ragard Lawrence R; Berg Christine D; Prorok Philip C
Prediction of true positive lung cancers in individuals with abnormal suspicious chest radiographs: a prostate, lung, colorectal, and ovarian cancer screening trial study.
Fan Ya-Guang; Hu Ping; Jiang Yong; Chang Run-Sheng; Yao Shu-Xiang; Wang Wendy; He Jie; Prorok Philip; Qiao You-Lin
Association between sputum atypia and lung cancer risk in an occupational cohort in Yunnan, China.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Philip Prorok (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Doria-Rose V Paul; Marcus Pamela M; Szabo Eva; Tockman Melvyn S; Melamed Myron R; Prorok Philip C
Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study.
Cancer 2009;115(21):5007-17.
2009: Tammemagi Martin Carl; Freedman Matthew T; Pinsky Paul F; Oken Martin M; Hu Ping; Riley Thomas L; Ragard Lawrence R; Berg Christine D; Prorok Philip C
Prediction of true positive lung cancers in individuals with abnormal suspicious chest radiographs: a prostate, lung, colorectal, and ovarian cancer screening trial study.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(6):710-21.
2009: Fan Ya-Guang; Hu Ping; Jiang Yong; Chang Run-Sheng; Yao Shu-Xiang; Wang Wendy; He Jie; Prorok Philip; Qiao You-Lin
Association between sputum atypia and lung cancer risk in an occupational cohort in Yunnan, China.
Chest 2009;135(3):778-85.
2009: Grubb Robert L; Black Amanda; Izmirlian Grant; Hickey Thomas P; Pinsky Paul F; Mabie Jerome E; Riley Thomas L; Ragard Lawrence R; Prorok Philip C; Berg Christine D; Crawford E David; Church Timothy R; Andriole Gerald L;
Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(3):748-51.
2009: Pinsky Paul F; Schoen Robert E; Weissfeld Joel L; Church Timothy; Yokochi Lance A; Doria-Rose V Paul; Prorok Philip
The yield of surveillance colonoscopy by adenoma history and time to examination.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2009;7(1):86-92.
2009: Xu Jian-Lun; Prorok Philip C
On testing independence of repeated screening tests.
Journal of medical screening 2009;16(1):50; author reply 51.
2008: Grubb Robert L; Pinsky Paul F; Greenlee Robert T; Izmirlian Grant; Miller Anthony B; Hickey Thomas P; Riley Thomas L; Mabie Jerome E; Levin David L; Chia David; Kramer Barnett S; Reding Douglas J; Church Timothy R; Yokochi Lance A; Kvale Paul A; Weissfeld Joel L; Urban Donald A; Buys Saundra S; Gelmann Edward P; Ragard Lawrence R; Crawford E David; Prorok Philip C; Gohagan John K; Berg Christine D; Andriole Gerald L
Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial.
BJU international 2008;102(11):1524-30.
2008: Baker Stuart G; Kramer Barnett S; Prorok Philip C
Early reporting for cancer screening trials.
Journal of medical screening 2008;15(3):122-9.
2007: Tammemagi C Martin; Freedman Matthew T; Church Timothy R; Oken Martin M; Hocking William G; Kvale Paul A; Hu Ping; Riley Thomas L; Ragard Lawrence R; Prorok Philip C; Berg Christine D
Factors associated with human small aggressive non small cell lung cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(10):2082-9.
2007: Pinsky P F; Miller A; Kramer B S; Church T; Reding D; Prorok P; Gelmann E; Schoen R E; Buys S; Hayes R B; Berg C D
Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial.
American journal of epidemiology 2007;165(8):874-81.
2005: Oken Martin M; Marcus Pamela M; Hu Ping; Beck Thomas M; Hocking William; Kvale Paul A; Cordes Jill; Riley Thomas L; Winslow Stephen D; Peace Steven; Levin David L; Prorok Philip C; Gohagan John K;
Baseline chest radiograph for lung cancer detection in the randomized Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Journal of the National Cancer Institute 2005;97(24):1832-9.
2005: Buys Saundra S; Partridge Edward; Greene Mark H; Prorok Philip C; Reding Douglas; Riley Thomas L; Hartge Patricia; Fagerstrom Richard M; Ragard Lawrence R; Chia David; Izmirlian Grant; Fouad Mona; Johnson Christine C; Gohagan John K;
Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial.
American journal of obstetrics and gynecology 2005;193(5):1630-9.
2005: Weissfeld Joel L; Schoen Robert E; Pinsky Paul F; Bresalier Robert S; Church Timothy; Yurgalevitch Susan; Austin Joseph H; Prorok Philip C; Gohagan John K;
Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial.
Journal of the National Cancer Institute 2005;97(13):989-97.
2005: Andriole Gerald L; Levin David L; Crawford E David; Gelmann Edward P; Pinsky Paul F; Chia David; Kramer Barnett S; Reding Douglas; Church Timothy R; Grubb Robert L; Izmirlian Grant; Ragard Lawrence R; Clapp Jonathan D; Prorok Philip C; Gohagan John K;
Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.
Journal of the National Cancer Institute 2005;97(6):433-8.
2005: Pinsky Paul F; Andriole Gerald L; Kramer Barnett S; Hayes Richard B; Prorok Philip C; Gohagan John K;
Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trial.
The Journal of urology 2005;173(3):746-50; discussion 750-1.
2004: Xu Jian-Lun; Fagerstrom Richard M; Prorok Philip C; Kramer Barnett S
Estimating the cumulative risk of a false-positive test in a repeated screening program.
Biometrics 2004;60(3):651-60.
2004: Andriole Gerald L; Reding Douglas; Hayes Richard B; Prorok Philip C; Gohagan John K;
The prostate, lung, colon, and ovarian (PLCO) cancer screening trial: Status and promise.
Urologic oncology 2004;22(4):358-61.
2004: Baker Stuart G; Kramer Barrett S; Prorok Philip C
Comparing breast cancer mortality rates before-and-after a change in availability of screening in different regions: extension of the paired availability design.
BMC medical research methodology 2004;4():12.
2004: Baker Stuart G; Kramer Barnett S; Prorok Philip C
Development tracks for cancer prevention markers.
Disease markers 2004;20(2):97-102.
2003: Xu Jian-Lun; Prorok Philip C
Modelling and analysing exchangeable binary data with random cluster sizes.
Statistics in medicine 2003;22(15):2401-16.
2003: Schoen Robert E; Pinsky Paul F; Weissfeld Joel L; Bresalier Robert S; Church Timothy; Prorok Philip; Gohagan John K;
Results of repeat sigmoidoscopy 3 years after a negative examination.
JAMA : the journal of the American Medical Association 2003;290(1):41-8.
2003: Baker Stuart G; Erwin Diane; Kramer Barnett S; Prorok Philip C
Using observational data to estimate an upper bound on the reduction in cancer mortality due to periodic screening.
BMC medical research methodology 2003;3():4.
2002: Baker Stuart G; Kramer Barnett S; Prorok Philip C
Statistical issues in randomized trials of cancer screening.
BMC medical research methodology 2002;2():11.
2002: Weissfeld Joel L; Ling Bruce S; Schoen Robert E; Bresalier Robert S; Riley Thomas; Prorok Philip C;
Adherence to repeat screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Cancer 2002;94(10):2569-76.
2002: de Koning Harry J; Auvinen Anssi; Berenguer Sanchez Antonio; Calais da Silva Fernando; Ciatto Stefano; Denis Louis; Gohagan John K; Hakama Matti; Hugosson Jonas; Kranse Ries; Nelen Vera; Prorok Philip C; Schröder Fritz H;
Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial.
International journal of cancer. Journal international du cancer 2002;97(2):237-44.
2000: O'Brien B; Nichaman L; Browne J E; Levin D L; Prorok P C; Gohagan J K;
Coordination and management of a large multicenter screening trial: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
Controlled clinical trials 2000;21(6 Suppl):310S-328S.
2000: Prorok P C; Andriole G L; Bresalier R S; Buys S S; Chia D; Crawford E D; Fogel R; Gelmann E P; Gilbert F; Hasson M A; Hayes R B; Johnson C C; Mandel J S; Oberman A; O'Brien B; Oken M M; Rafla S; Reding D; Rutt W; Weissfeld J L; Yokochi L; Gohagan J K;
Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
Controlled clinical trials 2000;21(6 Suppl):273S-309S.
2000: Gohagan J K; Prorok P C; Hayes R B; Kramer B S;
The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status.
Controlled clinical trials 2000;21(6 Suppl):251S-272S.
2000: Hartge P; Hayes R; Reding D; Sherman M E; Prorok P; Schiffman M; Buys S
Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the prostate, lung, colon, and ovarian cancer screening trial.
American journal of obstetrics and gynecology 2000;183(5):1232-7.
2000: Marcus P M; Bergstralh E J; Fagerstrom R M; Williams D E; Fontana R; Taylor W F; Prorok P C
Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up.
Journal of the National Cancer Institute 2000;92(16):1308-16.
2000: Connor R J; Boer R; Prorok P C; Weed D L
Investigation of design and bias issues in case-control studies of cancer screening using microsimulation.
American journal of epidemiology 2000;151(10):991-8.
1999: Hankey B F; Feuer E J; Clegg L X; Hayes R B; Legler J M; Prorok P C; Ries L A; Merrill R M; Kaplan R S
Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.
Journal of the National Cancer Institute 1999;91(12):1017-24.
1999: Xu J L; Fagerstrom R M; Prorok P C
Estimation of post-lead-time survival under dependence between lead-time and post-lead-time survival.
Statistics in medicine 1999;18(2):155-62.
1999: Marcus P M; Prorok P C
Reanalysis of the Mayo Lung Project data: the impact of confounding and effect modification.
Journal of medical screening 1999;6(1):47-9.
1998: Xu J L; Prorok P C
Estimating a distribution function of the tumor size at metastasis.
Biometrics 1998;54(3):859-64.
1998: Cronin K A; Weed D L; Connor R J; Prorok P C
Case-control studies of cancer screening: theory and practice.
Journal of the National Cancer Institute 1998;90(7):498-504.
1997: Xu J L; Prorok P C
Nonparametric estimation of solid cancer size at metastasis and probability of presenting with metastasis at detection.
Biometrics 1997;53(2):579-91.
1997: Kramer B S; Gohagan J K; Prorok P C
Is screening for prostate cancer the current gold standard?--"no".
European journal of cancer (Oxford, England : 1990) 1997;33(3):348-53.
1996: Prorok P C; Potosky A L; Gohagan J K; Kramer B S
Prostate cancer screening: current issues.
Cancer treatment and research 1996;86():93-112.
1995: Xu J L; Prorok P C
Non-parametric estimation of the post-lead-time survival distribution of screen-detected cancer cases.
Statistics in medicine 1995;14(24):2715-25.
1994: Kramer B S; Gohagan J; Prorok P C
NIH Consensus 1994: screening.
Gynecologic oncology 1994;55(3 Pt 2):S20-1.
1994: Prorok P
The National Cancer Institute Multi-Screening Trial.
The Canadian journal of oncology 1994;4 Suppl 1():98-9; discussion 100-1.
1994: Gohagan J K; Prorok P C; Kramer B S; Cornett J E
Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute.
The Journal of urology 1994;152(5 Pt 2):1905-9.
1994: Connor R J; Prorok P C
Issues in the mortality analysis of randomized controlled trials of cancer screening.
Controlled clinical trials 1994;15(2):81-99.
1994: Kafadar K; Prorok P C
A data-analytic approach for estimating lead time and screening benefit based on survival curves in randomized cancer screening trials.
Statistics in medicine 1994;13(5-7):569-86.
1993: Kramer B S; Brown M L; Prorok P C; Potosky A L; Gohagan J K
Prostate cancer screening: what we know and what we need to know.
Annals of internal medicine 1993;119(9):914-23.
1993: Kramer B S; Gohagan J; Prorok P C; Smart C
A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers.
Cancer 1993;71(2 Suppl):589-93.
1992: Prorok P C
Epidemiologic approach for cancer screening. Problems in design and analysis of trials.
The American journal of pediatric hematology/oncology 1992;14(2):117-28.
1991: Connor R J; Prorok P C; Weed D L
The case-control design and the assessment of the efficacy of cancer screening.
Journal of clinical epidemiology 1991;44(11):1215-21.
1990: Prorok P C; Connor R J; Baker S G
Statistical considerations in cancer screening programs.
The Urologic clinics of North America 1990;17(4):699-708.
1990: Zurawski V R; Sjovall K; Schoenfeld D A; Broderick S F; Hall P; Bast R C; Eklund G; Mattsson B; Connor R J; Prorok P C
Prospective evaluation of serum CA 125 levels in a normal population, phase I: the specificities of single and serial determinations in testing for ovarian cancer.
Gynecologic oncology 1990;36(3):299-305.
1986: Aron J L; Prorok P C
An analysis of the mortality effect in a breast cancer screening study.
International journal of epidemiology 1986;15(1):36-43.
1986: Prorok P C; Connor R J
Screening for the early detection of cancer.
Cancer investigation 1986;4(3):225-38.
1984: Black M M; Hankey B F; Aron J L; Prorok P C
Possible immunological implications of an association between the stages of first and second independent breast cancers.
Breast cancer research and treatment 1984;4(2):95-104.
1981: Prorok P C; Hankey B F; Bundy B N
Concepts and problems in the evaluation of screening programs.
Journal of chronic diseases 1981;34(4):159-71.

Sign-in to see more